@phdthesis{Portmann2023,
  author    = {Portmann, Johannes},
  title     = {Accelerated inversion recovery MRI of the myocardium using spiral acquisition},
  doi       = {10.25972/OPUS-30282},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-302822},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2023},
  abstract  = {This work deals with the acceleration of cardiovascular MRI for the assessment of functional information in steady-state contrast and for viability assessment during the inversion recovery of the magnetization. Two approaches are introduced and discussed in detail. MOCO-MAP uses an exponential model to recover dynamic image data, IR-CRISPI, with its low-rank plus sparse reconstruction, is related to compressed sensing. MOCO-MAP is a successor to model-based acceleration of parametermapping (MAP) for the application in the myocardial region. To this end, it was augmented with a motion correction (MOCO) step to allow exponential fitting the signal of a still object in temporal direction. Iteratively, this introduction of prior physical knowledge together with the enforcement of consistency with the measured data can be used to reconstruct an image series from distinctly shorter sampling time than the standard exam (< 3 s opposed to about 10 s). Results show feasibility of the method as well as detectability of delayed enhancement in the myocardium, but also significant discrepancies when imaging cardiac function and artifacts caused already by minor inaccuracy of the motion correction. IR-CRISPI was developed from CRISPI, which is a real-time protocol specifically designed for functional evaluation of image data in steady-state contrast. With a reconstruction based on the separate calculation of low-rank and sparse part, it employs a softer constraint than the strict exponential model, which was possible due to sufficient temporal sampling density via spiral acquisition. The low-rank plus sparse reconstruction is fit for the use on dynamic and on inversion recovery data. Thus, motion correction is rendered unnecessary with it. IR-CRISPI was equipped with noise suppression via spatial wavelet filtering. A study comprising 10 patients with cardiac disease show medical applicability. A comparison with performed traditional reference exams offer insight into diagnostic benefits. Especially regarding patients with difficulty to hold their breath, the real-time manner of the IR-CRISPI acquisition provides a valuable alternative and an increase in robustness. In conclusion, especially with IR-CRISPI in free breathing, a major acceleration of the cardiovascular MR exam could be realized. In an acquisition of less than 100 s, it not only includes the information of two traditional protocols (cine and LGE), which take up more than 9.6 min, but also allows adjustment of TI in retrospect and yields lower artifact level with similar image quality.},
  subject      = {Kernspintomografie},
  language  = {en}
}
@phdthesis{Kirchmaier2010,
  author    = {Kirchmaier, Bettina Carmen},
  title     = {Characterization of the Popeye domain containing gene family in zebrafish},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-49413},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2010},
  abstract  = {The Popeye domain containing (Popdc) gene family of membrane proteins is predominantly expressed in striated and smooth muscle tissues and has been shown to act as novel cAMP-binding proteins. In mice, loss of Popdc1 and Popdc2, respectively, affects sinus node function in the postnatal heart in an age and stress-dependent manner. In this thesis, I examined gene expression pattern and function of the Popdc gene family during zebrafish development with an emphasis on popdc2. Expression of the zebrafish popdc2 was exclusively present in cardiac and skeletal muscle during cardiac development, whereas popdc3 was expressed in striated muscle tissue and in distinct regions of the brain. In order to study the function of these genes, an antisense morpholino-based knockdown approach was used. Knockdown of popdc2 resulted in aberrant development of facial and tail musculature. In the heart, popdc2 morphants displayed irregular ventricular contractions with 2:1 and 3:1 ventricular pauses. Recordings of calcium transients using a transgenic indicator line Tg(cmlc2:gCaMP)s878 and selective plane illumination microscopy (SPIM) revealed the presence of an atrioventricular (AV) block in popdc2 morphants as well as a complete heart block. Interestingly, preliminary data revealed that popdc3 morphants developed a similar phenotype. In order to find a morphological correlate for the observed AV conduction defect, I studied the structure of the AV canal in popdc2 morphants using confocal analysis of hearts of the transgenic line Tg(cmlc2:eGFP-ras)s883, which outlines individual cardiac myocytes with the help of membrane-localized GFP. However, no evidence for morphological alterations was obtained. To ensure that the observed arrhythmia phenotype in the popdc2 morphant was based on a myocardial defect and not caused by defective valve development, live imaging was performed revealing properly formed valves. Thus, in agreement with the data obtained in knockout mice, popdc2 and popdc3 genes in zebrafish are involved in the regulation of cardiac electrical activity. However, both genes are not required for cardiac pacemaking, but they play essential roles in AV conduction. In order to elucidate the biological importance of cAMP-binding, wild type Popdc1 as well as mutants with a significant reduction in binding affinity for cAMP in vitro were overexpressed in zebrafish embryos. Expression of wild type Popdc1 led to a cardiac insufficiency phenotype characterized by pericardial edema and venous blood retention. Strikingly, the ability of the Popdc1 mutants to induce a cardiac phenotype correlated with the binding affinity for cAMP. These data suggest that cAMP-binding represents an important biological property of the Popdc protein family.},
  subject      = {Zebrab{\"a}rbling},
  language  = {en}
}
@phdthesis{Wu2006,
  author    = {Wu, Rongxue},
  title     = {Integrins and SPARC : potential implications for cardiac remodeling},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-17531},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2006},
  abstract  = {Der enorme Umbau des Herzgewebes, wie man ihn nach Druck{\"u}berlastung des Ventrikels oder MyokardInfarkt beobachten kann, gilt als eine der kausalen Ursachen des Herzversagens. Die Ver{\"a}nderungen in der Architektur des Herzens beeinflussen die mechanischen Eigenschaften des Herzmuskels, begr{\"u}ndet sind sie jedoch in Anpassungsprozessen auf der zellul{\"a}ren Ebene vor allem in einer Modulation der Expression bestimmter Gene. Gemeinsam mit Integrinen, den Transmembran-Rezeptoren, welche die extrazellul{\"a}re Umgebung mit dem intrazellul{\"a}ren Zytoskelett verbinden, geh{\"o}ren Proteine der extrazellul{\"a}ren Matrix (ECM) und matrizellul{\"a}re Proteine zu den Schl{\"u}sselkomponenten, die den Umbauprozess im Herzen steuern. Aus diesen Gr{\"u}nden hatte diese Doktorarbeit zum Ziel, die Rolle der Integrine f{\"u}r die Regulation der Genexpression und die Leistungsf{\"a}higkeit des Herzmuskels w{\"a}hrend der durch Druck{\"u}berlastung oder myokardialen Infarkt (MI) hervorgerufenen Wundheilungsprozesse zu analysieren. Um die Beteiligung von Integrin Beta 1 zu untersuchen, wurde ein experimentelles Modell der Druck{\"u}berlastung im Mausherzen (aortic banding; Konstriktion der Aorta; AB) eingesetzt, wobei M{\"a}use mit einer konditionalen, Herz-spezifischen Deletion des Integrin Beta 1 Gens untersucht wurden. Ein besonderes Augenmerk wurde dabei auf die physiologischen Unterschiede und eine ver{\"a}nderte Genexpression im gestressten Herzen in An- oder Abwesenheit von Integrin Beta 1 gelegt. Interessanterweise wurden die M{\"a}use, welche eine Kombination aus Integrin knock-out Allel und dem Kardiomyozyten-spezifischen konditionalen knock-out Allel von Integrin Beta 1 aufwiesen im normalen Mendelschen Verh{\"a}ltnis geboren und wuchsen normal auf. Obwohl diese Tiere immer noch geringe Mengen von Integrin Beta 1 in ihrem Herzen aufwiesen (exprimiert von nicht-Myozyten), besaßen diese M{\"a}use eine ver{\"a}nderte Herzfunktion und waren sehr sensitiv gegen{\"u}ber AB. Im Gegensatz zu der kompensatorischen hypertrophischen Reaktion, die in Wildtyp M{\"a}usen zu beobachten war, zeigte sich in den Integrin Beta 1-defizienten Mausherzen kein Gewebeumbau. Auch die erh{\"o}hte Expression von verschiedenen ECM Proteinen, insbesondere die verst{\"a}rkte Expression des matrizellul{\"a}ren Proteins SPARC, unterblieb nach AB in den Integrin Beta 1-defizienten Tieren. Interessanterweise konnte auch eine transiente Erh{\"o}hung der SPARC mRNA w{\"a}hrend der Umbauprozesse im Herzen in Folge von myokardialem Infarkt (MI) mittels cDNA Makroarrays festgestellt werden. In der Tat fanden sich gr{\"o}ßere Mengen von SPARC bereits 2 Tage (~2,5-fach erh{\"o}ht), 7 Tage (~4-fach erh{\"o}ht) und 1 Monat (~2-fach erh{\"o}ht) nach MI, w{\"a}hrend ein spezifischer Inhibitor der Integrin alpha v Untereinheit diese Hochregulation von SPARC in vivo verhinderte. Immunfluoreszenz Untersuchungen von Herzgewebe verdeutlichten, dass sich die erh{\"o}hte Expression von SPARC auf das Infarktareal beschr{\"a}nkte, dass die Expression von SPARC nach einer anf{\"a}nglichen Erh{\"o}hung im Verlauf von 1 Monaten wieder auf das Anfangsniveau zur{\"u}ckging und dass die verst{\"a}rkte Expression von der Einwanderung von Fibroblasten in das isch{\"a}mische Herzgewebe begleitet war. In vitro stimulierten die Wachstumsfaktoren TGF-Beta 1 und PDGF-BB die Expression von SPARC durch Fibroblasten. Wie sich an Hand von ELISA und Western Blot Untersuchungen feststellen ließ, war die Inhibition von Integrin Beta v nicht in der Lage, die durch TGF-Beta 1 oder PDGF induzierte Sekretion von SPARC zu beeinflussen. Jedoch zeigte sich, dass Vitronektin, ein Ligand von Integrin alpha v, sowohl die Sekretion von TGF-Beta 1 als auch von PDGF-BB durch Kardiomyozyten induzierte und diese Reaktion wurde durch den Integrin alpha v Inhibitor komplett unterdr{\"u}ckt. In funktioneller Hinsicht wirkte SPARC auf die durch ECM Proteine induzierte Migration von Fibroblasten ein, so dass man davon ausgehen kann, dass die lokale Freisetzung von SPARC nach myokardialem Infarkt zur Wundheilung im Herzen beitr{\"a}gt. Zusammenfassend l{\"a}ßt die Kombination der in vivo und in vitro erhobenen experimentellen Daten den Schluss zu, dass mehrere Integrin Untereinheiten eine entscheidende Rolle w{\"a}hrend der Gewebeumbildung im Herzen spielen. Integrin-abh{\"a}ngige Genexpressionsereignisse wie beispielsweise die erh{\"o}hte Expression von SPARC nach MI sind entscheidend an der Koordination der Wundheilung beteiligt. Diese Prozesse scheinen auf einer komplexen Wechselwirkung und Kommunikation zwischen verschiedenen Zelltypen wie Kardiomyozyten und Fibroblasten zu beruhen, um lokal begrenzt eine Heilung und Vernarbung des verletzten Gewebes zu regulieren. Die Aufkl{\"a}rung des fein abgestimmten Wechselspiels zwischen Integrinen matrizellul{\"a}ren Proteinen wie SPARC und Wachstumsfaktoren wird sicherlich zu einem besseren und klinisch nutzbarem Verst{\"a}ndnis der molekularen Mechanismen des Gewebeumbaus im Herzen beitragen.},
  subject      = {Integrine},
  language  = {en}
}
@phdthesis{Jager2002,
  author    = {Jager, Tertia ¬de¬},
  title     = {Estrogen action in the myocardium},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-1182573},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2002},
  abstract  = {Cardiovascular disease is the leading cause of mortality in both men and women in the Western world. Earlier observations have pointed out that pre-menopausal women have a lower risk of developing cardiovascular disease than age-matched men, with an increase in risk after the onset of menopause. This observation has directed the attention to estrogen as a potential protective factor in the heart. So far the focus of research and clinical studies has been the vascular system, leaving the current knowledge on the role of estrogen in the myocardium itself rather scarce. Functional estrogen receptor-alpha as well as -beta have recently been identified in the myocardium, making the myocardium an estrogen target organ. The focus of this thesis was 1) to investigate the role of estrogen and estrogen receptors in modulating myocardial gene expression both in vivo in an animal model for cardiac hypertrophy (spontaneously hypertensive rats; SHR), as well as in vitro in isolated neonatal cardiomyocytes, 2) to investigate the mechanisms of the rapid induction of an estrogen target gene, the early growth response gene-1 (Egr-1) and 3) to initiate the search for novel estrogen target genes in the myocardium. 1) The effects of estrogen on the expression of one of the major myocardial specific contractile proteins, the alpha-myosin heavy chain (alpha-MHC) have been investigated. In ovarectomised animals treated either with 17beta-estradiol alone or in combination with a specific estrogen receptor antagonist, ICI 182780, it was shown that both alpha-MHC mRNA and protein were upregulated by estrogen in an estrogen receptor specific manner. The in vivo results were confirmed in vitro in isolated neonatal cardiomyocytes which showed that estrogen has a direct action on the myocardium potent enough to upregulate the expression of alpha-MHC. Furthermore it was shown that the alpha-MHC promoter is induced by estrogen in an estrogen receptor-dependent manner and first investigations into the mechanisms involved in this upregulation identified Egr-1 as a potential transcription factor which, upon induction by estrogen, drives the expression of the alpha-MHC promoter. 2) Previously it was shown that Egr-1 is rapidly induced by estrogen in an estrogen receptor-dependent manner which was mediated via 5 serum response elements (SREs) in the promoter region and surprisingly not via the estrogen response elements (EREs). In this study it was shown that estrogen-treatment of cardiomyocytes resulted in the recruitment of serum response factor (SRF), or an antigenically related protein, to the SREs in the Egr-1 promoter, which was specifically inhibited by the estrogen receptor antagonist ICI 182780. Transfection experiments showed that estrogen induced a heterologous promoter consisting only of 5 tandem repeats of the c-fos SRE in an ER-dependent manner, which identified SREs as promoter elements able to confer an estrogen response to target genes. 3) Potentially new target genes regulated by estrogen in vivo were analysed using hearts of ovarectomised animals as well as ovarectomised animals treated with estrogen. Analyses of cDNA microarray filters containing 1250 known genes identified 24 genes that were modified by estrogen in vivo. Among these genes, some might have potentially important functions in the heart and further analyses of these genes will create a more global picture of the role and function of estrogen in the myocardium. Taken together, the results showed that estrogen does have a direct action on the myocardium both by regulating the expression of myocardial specific genes in vivo, as well as exerting rapid non-nuclear effects in cardiac myocytes. It was shown that SREs in the promoter region of genes can confer an estrogen response to genes identifying SREs as important elements in regulation of genes by estrogen. Furthermore, 24 potentially new estrogen targets were identified in the myocardium, contributing to the general understanding of estrogen action in the myocardium.},
  subject      = {Herzmuskel},
  language  = {en}
}